Efficacy and safety of atazanavir-based highly active antiretroviral therapy in patients with virologic suppression switched from a stable, boosted or unboosted protease inhibitor treatment regimen: the SWAN Study (AI424-097) 48-week results (Q42619329)
Jump to navigation
Jump to search
scientific article published on 25 April 2007
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Efficacy and safety of atazanavir-based highly active antiretroviral therapy in patients with virologic suppression switched from a stable, boosted or unboosted protease inhibitor treatment regimen: the SWAN Study (AI424-097) 48-week results |
scientific article published on 25 April 2007 |
Statements
Efficacy and safety of atazanavir-based highly active antiretroviral therapy in patients with virologic suppression switched from a stable, boosted or unboosted protease inhibitor treatment regimen: the SWAN Study (AI424-097) 48-week results (English)
1 reference
Andrzej Horban
1 reference
Eric Van Wijngaerden
1 reference
Jose Gatell
1 reference
Dominique Salmon-Ceron
1 reference
Clifford Leen
1 reference
Victoria Wirtz
1 reference
Linda Odeshoo
1 reference
Monique Van den Dungen
1 reference
Claudia Gruber
1 reference
Emilio Ledesma
1 reference
SWAN Study Group
1 reference
1 reference